Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators to Follow-up the Activities of Different Cancer Pathologies
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hepatocellular Carcinoma
- Sponsor
- Hospices Civils de Lyon
- Enrollment
- 4000
- Locations
- 1
- Primary Endpoint
- Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019)
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments).
Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma between 2017 and 2020.
Exclusion Criteria
- •Patients who did not allow the reuse of their medical data for research
Outcomes
Primary Outcomes
Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019)
Time Frame: 24 months
The difference between a set of different activity indicators will be compared between 2020 and the average activities of previous periods (2017-2019)